LEADER 04538nam 2200613Ia 450 001 9910830235503321 005 20230721005227.0 010 $a1-4443-6027-2 010 $a1-282-13961-4 010 $a9786612139611 010 $a1-4443-1180-8 010 $a1-4443-1179-4 035 $a(CKB)1000000000719916 035 $a(EBL)428258 035 $a(OCoLC)437112324 035 $a(SSID)ssj0000354292 035 $a(PQKBManifestationID)11264308 035 $a(PQKBTitleCode)TC0000354292 035 $a(PQKBWorkID)10302581 035 $a(PQKB)11578873 035 $a(MiAaPQ)EBC428258 035 $a(EXLCZ)991000000000719916 100 $a20080908d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aHandbook of hypertension$b[electronic resource] /$fMark C. Houston 210 $aChichester, West Sussex ;$aHoboken, NJ $cWiley-Blackwell$d2009 215 $a1 online resource (414 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-8250-4 320 $aIncludes bibliographical references and index. 327 $aCover; Contents; Abbreviations; Part 1 General Introduction to Hypertension; Hypertension Prevalence and Consequences; Hypertension Syndrome; Subsets of Hypertension Approach to Treatment; Clinical Hypertension Trials: A Perspective; Vascular Biology and Hypertension; Blood Vessel Structure; Endothelial Function and Dysfunction; New Treatment Approach to Hypertension Based on Concepts of Endothelial Dysfunction and Vascular Biology; Treatment of Impaired Endothelial Function: A Global CV Approach; Part 2 What is Hypertension; Hypothesis: Essential Hypertension and End-Organ Damage 327 $aHypertension Classification and Guidelines WorldwideHypertension Guidelines; Global CV Risk Calculation; Secondary Hypertension; BP Measurement; Hypertension-Atherosclerotic Syndrome; Normotensive Hypertension and Hypertension Syndromes; Prehypertension; Part 3 Treatment of Hypertension; Nonpharmacologic Treatment of Hypertension; Nutrition, Vitamins, Minerals, Antioxidants, Dietary, and Nutraceutical Supplements in the Prevention and Treatment of Hypertension; Nutritional Intervention, Prevention, and Treatment of Hypertension Trials and Consensus Reports 327 $aFurther Reading on Nutrition and Dietary SupplementsThe DASH Diets: DASH-I and DASH-II Sodium; The Premier Clinical Trial; Obesity; Exercise Activities and Kilocalories Used; Approaches to Selection of Antihypertensive Therapy; Hemodynamics in Hypertension; Hemodynamic Effects of Antihypertensive Drugs; Part 4 Problems Associated with Hypertension; Hypertension-Related End-Organ Damage; Life Expectancy and Blood Pressure (Man, 35 Years Old); Systolic, Diastolic, and Pulse Pressure Concepts; Part 5 The Clinical Trials of Hypertension 327 $aClinical Hypertension Trials and Antihypertensive Drug TherapyTreatment of Hypertension: Questions Posed; Clinical Hypertension Trials: Important Clinical Points; Diuretic/BB Clinical Trials in Mild-to-Moderate Hypertension and CHD: Summary; Meta-Analysis of Randomized Controlled Clinical Hypertension Trials with Antihypertensive Drug Therapy; Meta-Analysis by BP Lowering Treatment Trialists Collaboration; Staessen, Wang, and Thijs Meta-Analysis: Summary of Clinical Trials in Hypertension and Clinical Outcomes; Further Reading: Health Outcomes Analysis for Clinical Hypertension Trials 327 $aSCAT 330 $aWhen treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan. The Handbook of Hypertension is a comprehensive review of the evidence base for hypertension and associated disease, providing tables, figures, charts, and summaries of principal findings from clinical studies on hypertension - putting vital information within reach of the busy practitioner. Containing the most recent guid 606 $aHypertension$vHandbooks, manuals, etc 606 $aRenal hypertension 615 0$aHypertension 615 0$aRenal hypertension. 676 $a616.1/32 676 $a616.132 700 $aHouston$b Mark C$01638529 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830235503321 996 $aHandbook of hypertension$93981026 997 $aUNINA